BioSpace News Archive

Quest Diagnostics, the leader in diagnostic information services, released its 2022 Corporate Responsibility Report.

Genprex, Inc. today announced that its Chief Financial Officer, Ryan Confer, will be providing an overview of the Company’s gene therapies for cancer and diabetes at the upcoming H.C. Wainwright 25th Annual Global Investment Conference.

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that enrollment in the PL9643 MELODY-1 Phase 3 study in dry eye disease (DED) is complete, with 570 patients enrolled.

Vividion Therapeutics, Inc. and a wholly owned and independently operated subsidiary of Bayer AG, announced that Dr. Shawn Rose, M.D. Ph.D., has joined the company as Chief Development Officer, Immunology, reporting to our Chief Executive Officer, Aleksandra Rizo.

Wiley (NYSE: WLY and WLYB), a global knowledge company and a leader in research, publishing, and knowledge solutions today reported results for the first quarter ended July 31, 2023.

ProQR Therapeutics NV. today announced that Company management will participate in the HC Wainwright 25th Annual Global Investment Conference.

BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, is hosting today a virtual KOL event titled NE3107―Putting Data in Context, ahead of the upcoming Phase 3 results in Alzheimer’s Disease.

Jaguar today announced that Karen Brunke, PhD, the company’s EVP of Corporate and Business Development, has become a member of the Biotechnology Innovation Organization’s (BIO) Rare Disease and Orphan Drugs Committee.

The International Myeloma Foundation, in partnership with the National Medical Association, the W. Montague Cobb Institute, and the Student National Medical Association, sent a delegation of eleven IMF Medical Student Scholars for Health Equity in Myeloma along with their mentors to the 2023 NMA Annual Convention and Scientific Assembly, which took place in New Orleans, LA from July 29-August 2, 2023.

Nexcella, Inc. today announced that Nexcella NXC-201 clinical data will be presented by Ilya Rachman MD PhD and Gabriel Morris at the Healthcare Trailblazers Private Company Conference Thursday, October 26, 2023.